NewsroomHighlights
中文

Highlights

OpenAI acquires Orchestra Bio to build AI agents for drug development

OpenAI acquired biotech startup Orchestra Bio to strengthen its biotech business and build AI agents intended to speed up drug development.

Heat 0.0 2 reports 2 sources Since Updated Out of the hot window
  1. The DecoderOpenAI acquires Orchestra Bio to build AI agents that speed up drug development
  2. TechCrunch AIOpenAI acquires startup Orchestra Bio⁠ to beef up its biotech business